Expo

1st Annual Meeting AMM ASCENT
alliance for mrna medicines

1st Annual Meeting AMM ASCENT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to 1st Annual Meeting AMM ASCENT in Boston, MA

read more
2400 1800 Anemocyte.com
ESGCT Rome
european society gene therapy logo

ESGCT Rome

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to European Society of Gene & Cell Therapy 2024 in Rome, Italy

read more
1200 900 Anemocyte.com
BioJapan 2024
bio japan world business forum logo

BioJapan 2024

BIO International Convention 9-11 october 2024 | Yokohama, Japan.

read more
2400 1800 Anemocyte.com
Meeting on the Mesa
cell gene meeting

Meeting on the Mesa

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Cell & Gene Meeting on the Mesa in Phoenix, Arizona

read more
2400 1800 Anemocyte.com
CPHI Milan
CPHI milan event

CPHI Milan

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to CPHI Milan 2024

read more
2400 1800 Anemocyte.com
ATE24 Lisbon
advanced therapies europe

ATE24 Lisbon

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ATE24 Lisbon, Portugal

read more
2400 1800 Anemocyte.com
BIO International Convention
bio international convention

BIO International Convention

BIO International Convention 3-6 june 2024 | San Diego. Meet us at Italian Pavilion at booth #3623(Anemocyte table, H).

read more
1536 1152 Anemocyte.com
ISCT
international society gene therapy

ISCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ISCT 2024 in Vancouver

read more
2400 1800 Anemocyte.com
ASGCT
ASGT meeting

ASGCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ASGCT Annual Meeting 2024 in Baltimore

read more
2400 1800 Anemocyte.com

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961